Evidence map›Paper›PMID 40307849›Full record

ReviewHuman genomics2025

Advancing translational exposomics: bridging genome, exposome and personalized medicine.

Dimosthenis Sarigiannis, Spyros Karakitsios, Ourania Anesti, Arthur Stem, Damaskini Valvi, Susan C J Sumner, Leda Chatzi, Michael P Snyder, David C Thompson, Vasilis Vasiliou

Abstract readReview
In one paragraph

Review in Human genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Special Issue "Molecular Progression in Genome-Related Diseases".International journal of molecular sciences · 2026
    Article
  13. Review
  14. Review
  15. Exposomics: From Daily-Life Exposure Monitoring to Precision Prevention.International journal of exposome and toxicology · 2026
    Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dimosthenis SarigiannisNational Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, Athens, 11635, Greece. sarigiannis@eie.gr.
Spyros KarakitsiosNational Hellenic Research Foundation, 48 Vassileos Constantinou Avenue, Athens, 11635, Greece.
Ourania AnestiHERACLES Research Center on the Exposome and Health, Center for Interdisciplinary Research and Innovation, Aristotle University of Thessaloniki, Balkan Center, Bldg. B, 10th km Thessaloniki-Thermi Road, Thessaloniki, 57001, Greece.
Arthur StemDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, 06510, USA.
Damaskini ValviDepartment of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
Susan C J SumnerDepartments of Nutrition and Pharmacology, UNC Nutrition Research Institute, UNC Chapel Hill, Kannapolis, NC, 28010, USA.
Leda ChatziDepartment of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, CA, USA.
Michael P SnyderDepartment of Genetics, Stanford University School of Medicine, Stanford University, Stanford, CA, USA.
David C ThompsonDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, 06510, USA.
Vasilis VasiliouDepartment of Environmental Health Sciences, Yale School of Public Health, New Haven, CT, 06510, USA. vasilis.vasiliou@yale.edu.

Funding

Translational Research Support CoreP30ES007048 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROB S MCCONNELL · 1996 to 2026
$46.4M
The Mount Sinai Transdisciplinary Center on Early Environmental ExposuresP30ES023515 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Chris Gennings · 2014 to 2026
$21.3M
Year 2, Targeted and Clinical Assay Supplement to the NPH MCACU24CA268153 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SUMNER, SUSAN J · 2022 to 2025
$14.7M
SENSORS FOR WATER CONTAMINANT DETECTION AND MONITORINGP42ES033815 · NIEHS · YALE UNIVERSITY · PI Ying Chen · 2022 to 2026
$9.5M
Mouse Models for Alcohol Metabolism and Tissue InjuryR24AA022057 · NIAAA · YALE UNIVERSITY · PI VASILIOU, VASILIS · 2013 to 2022
$4.5M
Effects of DDE exposure on adipose tissue function, weight loss and metabolic improvement after bariatric surgery: A new paradigm for study of lipophilic chemicalsR01ES030364 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHATZI, VAIA LIDA · 2020 to 2024
$3.2M
Perfluoroalkyl substances and incident type 2 diabetes in a US population: A metabolome-genome investigationR01ES033688 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Damaskini Valvi · 2022 to 2026
$3.2M
Environmental Chemical Exposures and Longitudinal Changes of Glucose Metabolism, Insulin Sensitivity and B Cell Function in YouthR01ES029944 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHATZI, VAIA LIDA · 2019 to 2023
$3.1M
Longitudinal integration of environmental exposures, omics, and childhood NAFLD (LEON) StudyU01HG013288 · NHGRI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI AUNG, TUN (MAX) M, CHATZI, VAIA LIDA · 2023 to 2025
$2.4M
Translational Alcohol Research Program (TARP)T32AA028259 · NIAAA · YALE UNIVERSITY · PI COSGROVE, KELLY P., VASILIOU, VASILIS · 2020 to 2024
$1.8M
Early-life environmental exposure mixtures and biological age acceleration in children and adolescents: susceptibility, potential interactions and underlying mechanismsR01ES035773 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Damaskini Valvi · 2024 to 2026
$1.8M
PFAS and bone health over the life course in Hispanic/Latinos: emerging risk factors and underlying mechanismsR01ES036253 · NIEHS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHATZI, VAIA LIDA · 2025 to 2025
$710k
European Commission 101157269Leona M. and Harry B. Helmsley Charitable Trust G-2004-03820National Institutes of Health, United States AA022057National Institutes of Health, United States ES035148NCI NIH HHS U24 CA268153NHGRI NIH HHS U01 HG013288NIAAA NIH HHS R24 AA022057NIAAA NIH HHS T32 AA028259NIEHS NIH HHS ES03085NIEHS NIH HHS P30 ES007048NIEHS NIH HHS P30 ES023515NIEHS NIH HHS P42 ES033815NIEHS NIH HHS R01 ES029944NIEHS NIH HHS R01 ES030364NIEHS NIH HHS R01 ES033688NIEHS NIH HHS R01 ES035773NIEHS NIH HHS R01 ES036253NIEHS NIH HHS R21 ES035148NIH HHS AA028259NIH HHS ES030364NIH HHS ES033688NIH HHS ES033815NIH HHS U24CA268153
6 · The paper itself

Abstract

Understanding the interplay between genetic predisposition and environmental and lifestyle exposures is essential for advancing precision medicine and public health. The exposome, defined as the sum of all environmental exposures an individual encounters throughout their lifetime, complements genomic data by elucidating how external and internal exposure factors influence health outcomes. This treatise highlights the emerging discipline of translational exposomics that integrates exposomics and genomics, offering a comprehensive approach to decipher the complex relationships between environmental and lifestyle exposures, genetic variability, and disease phenotypes. We highlight cutting-edge methodologies, including multi-omics technologies, exposome-wide association studies (EWAS), physiology-based biokinetic modeling, and advanced bioinformatics approaches. These tools enable precise characterization of both the external and the internal exposome, facilitating the identification of biomarkers, exposure-response relationships, and disease prediction and mechanisms. We also consider the importance of addressing socio-economic, demographic, and gender disparities in environmental health research. We emphasize how exposome data can contextualize genomic variation and enhance causal inference, especially in studies of vulnerable populations and complex diseases. By showcasing concrete examples and proposing integrative platforms for translational exposomics, this work underscores the critical need to bridge genomics and exposomics to enable precision prevention, risk stratification, and public health decision-making. This integrative approach offers a new paradigm for understanding health and disease beyond genetics alone.

Indexed as

Environmental ExposureExposomeGenome, HumanGenomicsPrecision MedicineTranslational Research, BiomedicalGenetic Predisposition to DiseaseGenome-Wide Association StudyHumans

Identifiers

PMID40307849
PMCPMC12044731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.